FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001262581> ?p ?o ?g. }

• W2001262581 endingPage "65" @default.
• W2001262581 startingPage "54" @default.
• W2001262581 abstract "The aim of this study is to determine whether cardiotoxin III (CTX III) inhibited the metastasis in MDA-MB-231 cells and to further explain its possible mechanisms.The MTT assay, wound healing assay, Boyden chamber invasion assay, zymography analysis, reverse transcriptase polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), inhibitor assay, and Western blot analysis were used to reveal molecular events of CTX III in this study.During treatment with non-toxic doses of CTX III, not only cell migration and invasion were markedly suppressed but the expression/activity of matrix metalloproteinase-9 (MMP-9) was also significantly and selectively suppressed in a concentration-dependent manner. In addition, CTX III decreased the nuclear protein level of nuclear factor kappa B (NF-κB), and pretreatment with NF-κB inhibitor (PDTC) or IκB protease inhibitor (TPCK) also reduced MMP-9 expression/activity and cell migration. Our biochemical assays indicated that CTX III potently suppressed the phosphorylation of p38 mitogen-activated protein kinase (MAPK), phosphatidylinositide-3-kinase (PI3K) and Akt. Additionally, the treatment of inhibitors specific for p38 MAPK (SB203580) or PI3K (wortmannin) to cells could result in a reduced expression of NF-κB and MMP-9 expression, concomitantly with an inhibition on cell metastasis.These results demonstrated that CTX III inhibition of MDA-MB-231 cells may occur through inactivation of both PI3K/Akt and p38 MAPK signaling pathways, exerting inhibitory effects on NF-κB transcriptional factor, thereby decreasing the activity of MMP-9 and then posing an anti-metastatic effect in the cells." @default.
• W2001262581 created "2016-06-24" @default.
• W2001262581 creator A5006299777 @default.
• W2001262581 creator A5011007771 @default.
• W2001262581 creator A5017101265 @default.
• W2001262581 creator A5035294253 @default.
• W2001262581 creator A5039394836 @default.
• W2001262581 creator A5050401077 @default.
• W2001262581 date "2012-01-01" @default.
• W2001262581 modified "2023-09-26" @default.
• W2001262581 title "Antimetastatic potential of cardiotoxin III involves inactivation of PI3K/Akt and p38 MAPK signaling pathways in human breast cancer MDA-MB-231 cells" @default.
• W2001262581 cites W1488829562 @default.
• W2001262581 cites W1534551308 @default.
• W2001262581 cites W1578523240 @default.
• W2001262581 cites W1605046409 @default.
• W2001262581 cites W1800142641 @default.
• W2001262581 cites W1980590323 @default.
• W2001262581 cites W1981281558 @default.
• W2001262581 cites W1984065981 @default.
• W2001262581 cites W1992885568 @default.
• W2001262581 cites W1999735006 @default.
• W2001262581 cites W2012634687 @default.
• W2001262581 cites W2022233074 @default.
• W2001262581 cites W2034269086 @default.
• W2001262581 cites W2036285327 @default.
• W2001262581 cites W2040228331 @default.
• W2001262581 cites W2040577840 @default.
• W2001262581 cites W2045468646 @default.
• W2001262581 cites W2051616588 @default.
• W2001262581 cites W2052153607 @default.
• W2001262581 cites W2060630008 @default.
• W2001262581 cites W2065670848 @default.
• W2001262581 cites W2067976250 @default.
• W2001262581 cites W2068619840 @default.
• W2001262581 cites W2068919269 @default.
• W2001262581 cites W2071531606 @default.
• W2001262581 cites W2081010886 @default.
• W2001262581 cites W2094593262 @default.
• W2001262581 cites W2095383156 @default.
• W2001262581 cites W2097565006 @default.
• W2001262581 cites W2125558097 @default.
• W2001262581 cites W2147195519 @default.
• W2001262581 cites W2155642175 @default.
• W2001262581 cites W2421037982 @default.
• W2001262581 cites W4250908540 @default.
• W2001262581 cites W74605648 @default.
• W2001262581 cites W2041509523 @default.
• W2001262581 doi "https://doi.org/10.1016/j.lfs.2011.10.020" @default.
• W2001262581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22079475" @default.
• W2001262581 hasPublicationYear "2012" @default.
• W2001262581 type Work @default.
• W2001262581 sameAs 2001262581 @default.
• W2001262581 citedByCount "13" @default.
• W2001262581 countsByYear W20012625812013 @default.
• W2001262581 countsByYear W20012625812014 @default.
• W2001262581 countsByYear W20012625812016 @default.
• W2001262581 countsByYear W20012625812017 @default.
• W2001262581 countsByYear W20012625812018 @default.
• W2001262581 countsByYear W20012625812020 @default.
• W2001262581 countsByYear W20012625812022 @default.
• W2001262581 crossrefType "journal-article" @default.
• W2001262581 hasAuthorship W2001262581A5006299777 @default.
• W2001262581 hasAuthorship W2001262581A5011007771 @default.
• W2001262581 hasAuthorship W2001262581A5017101265 @default.
• W2001262581 hasAuthorship W2001262581A5035294253 @default.
• W2001262581 hasAuthorship W2001262581A5039394836 @default.
• W2001262581 hasAuthorship W2001262581A5050401077 @default.
• W2001262581 hasConcept C153911025 @default.
• W2001262581 hasConcept C184235292 @default.
• W2001262581 hasConcept C185592680 @default.
• W2001262581 hasConcept C2778308172 @default.
• W2001262581 hasConcept C51551487 @default.
• W2001262581 hasConcept C57074206 @default.
• W2001262581 hasConcept C62478195 @default.
• W2001262581 hasConcept C75217442 @default.
• W2001262581 hasConcept C86554907 @default.
• W2001262581 hasConcept C86803240 @default.
• W2001262581 hasConcept C95444343 @default.
• W2001262581 hasConcept C97029542 @default.
• W2001262581 hasConceptScore W2001262581C153911025 @default.
• W2001262581 hasConceptScore W2001262581C184235292 @default.
• W2001262581 hasConceptScore W2001262581C185592680 @default.
• W2001262581 hasConceptScore W2001262581C2778308172 @default.
• W2001262581 hasConceptScore W2001262581C51551487 @default.
• W2001262581 hasConceptScore W2001262581C57074206 @default.
• W2001262581 hasConceptScore W2001262581C62478195 @default.
• W2001262581 hasConceptScore W2001262581C75217442 @default.
• W2001262581 hasConceptScore W2001262581C86554907 @default.
• W2001262581 hasConceptScore W2001262581C86803240 @default.
• W2001262581 hasConceptScore W2001262581C95444343 @default.
• W2001262581 hasConceptScore W2001262581C97029542 @default.
• W2001262581 hasIssue "1-2" @default.
• W2001262581 hasLocation W20012625811 @default.
• W2001262581 hasLocation W20012625812 @default.
• W2001262581 hasOpenAccess W2001262581 @default.
• W2001262581 hasPrimaryLocation W20012625811 @default.
• W2001262581 hasRelatedWork W1976734851 @default.
• W2001262581 hasRelatedWork W1990575044 @default.

• next